Ernexa Therapeutics appoints Robert J. Spiegel to board
Ernexa Therapeutics appointed Robert J. Spiegel, M.D., FACP, to its Board of Directors as it advances ERNA-101 toward clinical development.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.